JAVIER ANTONIO
MONTERO MORENO
Investigador en el periodo 2008-2015
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)
2015
-
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome
Retina, Vol. 35, Núm. 12, pp. 2450-2456
2013
-
Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-Year outcome
British Journal of Ophthalmology, Vol. 97, Núm. 11, pp. 1447-1450
-
Spectral-domain optical coherence tomography study of macular structure as prognostic and determining factor for macular hole surgery outcome
Retina, Vol. 33, Núm. 6, pp. 1117-1122
2012
2011
-
Prevalence of age-related macular degeneration in Spain
British Journal of Ophthalmology, Vol. 95, Núm. 7, pp. 931-936
2010
-
Photodynamic therapy for chronic central serous chorioretinopathy
Acta Ophthalmologica, Vol. 88, Núm. 3, pp. 371-376
-
Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization
Retina, Vol. 30, Núm. 10, pp. 1609-1615
2009
-
A 1-year retrospective review of ranibizumab for naïve nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration
Retina, Vol. 29, Núm. 10, pp. 1444-1449
2006
-
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748